910443-97-9 Usage
Classification
Nonsteroidal anti-inflammatory drug (NSAID)
Indications
Used to treat pain and inflammation associated with conditions such as arthritis
Mechanism of Action
Inhibits the production of inflammatory chemicals in the body
Chemical Structure
Derivative of propionic acid with a trifluoromethyl group attached to the phenyl ring
Potency
More potent and longer-lasting than other NSAIDs in the same class due to the trifluoromethyl group
Dosage Forms
Available in tablets, capsules, and topical preparations
Usage
Typically used for short-term relief of symptoms
Administration
Should only be used as directed by a healthcare professional
Side Effects
May have potential side effects, including but not limited to gastrointestinal issues, renal impairment, and cardiovascular risks
Caution
Patients should be monitored closely for adverse reactions, and it should not be used in excess or for prolonged periods without medical supervision.
Check Digit Verification of cas no
The CAS Registry Mumber 910443-97-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,0,4,4 and 3 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 910443-97:
(8*9)+(7*1)+(6*0)+(5*4)+(4*4)+(3*3)+(2*9)+(1*7)=149
149 % 10 = 9
So 910443-97-9 is a valid CAS Registry Number.
910443-97-9Relevant academic research and scientific papers
Catalytic Asymmetric Synthesis of Unprotected β2-Amino Acids
Zhu, Chendan,Mandrelli, Francesca,Zhou, Hui,Maji, Rajat,List, Benjamin
, p. 3312 - 3317 (2021/04/07)
We report here a scalable, catalytic one-pot approach to enantiopure and unmodified β2-amino acids. A newly developed confined imidodiphosphorimidate (IDPi) catalyzes a broadly applicable reaction of diverse bis-silyl ketene acetals with a silylated aminomethyl ether, followed by hydrolytic workup, to give free β2-amino acids in high yields, purity, and enantioselectivity. Importantly, both aromatic and aliphatic β2-amino acids can be obtained using this method. Mechanistic studies are consistent with the aminomethylation to proceed via silylium-based asymmetric counteranion-directed catalysis (Si-ACDC) and a transition state to explain the enantioselectivity is suggested on the basis of density functional theory calculation.
